Ropivacaine Mesylate Injection 89.4 Mg & 198.2 Mg

• Customization: Available
• Application: Internal Medicine
• Usage Mode: Injection
• Model NO.: H20061257
• Suitable for: Adult
• State: Liquid
• Shape: Injection
• Type: Organic Chemicals
• Pharmaceutical Technology: Chemical Synthesis
• Drug Reg./Approval No.: H20061257
• Generic Name: Ropivacaine Mesylate Injection
• Validity Period: 48 Months
• Active Ingredient: Ropivacaine Mesylate 89.4mg / 119.2mg
• Packaging: 5 Ampoules
• Transport Package: Carton
• Trademark: HJT-PHARMA
• Origin: China
• HS Code: 3004909099
• Production Capacity: 100000/Month

Product Description

 

Product Description

Generic Name	Ropivacaine Mesylate Injection
Strength	89.4mg / 119.2mg
Packaging	10ml x 5 Ampoules

Ropivacaine Mesilate Injection is a local anesthetic belonging to the amide-type class of anesthetics. It is commonly used to induce local or regional anesthesia for surgical procedures and to manage acute pain. 

Indications:

Surgical Anesthesia: Used for procedures requiring local or regional anesthesia.

Acute Pain Management: Provides pain relief during labor and postoperatively.

Dosage and Administration:

Concentration: Available in various concentrations; the specific dosage depends on the type of block, the patient's condition, and the procedure's requirements.

Administration: Administered via injection by a qualified healthcare professional.

Contraindications:

Hypersensitivity to ropivacaine or other amide-type local anesthetics.

Not recommended for intravenous regional anesthesia (Bier block).

Warnings and Precautions:

Monitoring: Continuous monitoring of cardiovascular and respiratory vital signs is essential during administration.

Resuscitative Equipment: Ensure immediate availability of resuscitative equipment and medications.

Caution in Specific Populations: Use cautiously in patients with hepatic or renal impairment, cardiovascular disease, or in debilitated or elderly patients.

Adverse Reactions:

Common: Hypotension, nausea, vomiting, bradycardia, fever, and headache.

Serious: Central nervous system toxicity (e.g., seizures), cardiovascular complications (e.g., cardiac arrest), and allergic reactions.

Drug Interactions:

Caution when used with other local anesthetics or agents structurally related to amide-type local anesthetics due to additive toxic effects.

Monitor patients receiving class III antiarrhythmic drugs (e.g., amiodarone) due to potential additive cardiac effects.

Overdosage:

Symptoms: Central nervous system effects (e.g., seizures), cardiovascular depression, and respiratory arrest.

Management: Immediate discontinuation, supportive care, and symptomatic treatment.

Storage:

Store at controlled room temperature, protected from light.
Note: This summary provides general information about Ropivacaine Mesilate Injection. For detailed prescribing information, including specific dosing guidelines and comprehensive safety information, please refer to the official prescribing information or consult a healthcare professional

Company Profile

HENG JING TANG PHARMACEUTICAL CO., LTD. is a prominent pharmaceutical company based in Anhui Province, China. Established with a commitment to the research, development, manufacturing, and marketing of high-quality pharmaceutical products, the company specializes in both traditional Chinese medicine (TCM) and modern pharmaceutical solutions. Hengjingtang integrates modern technology with traditional Chinese medicine practices to create innovative, effective products aimed at improving public health.

Core Business Areas
The company is involved in a wide range of pharmaceutical sectors, including:

• Traditional Chinese Medicine (TCM): Specializing in the production and sale of Chinese herbal medicine and TCM-based formulations.
• Prescription Drugs: Development and manufacturing of prescription drugs, focusing on various therapeutic areas, including cardiovascular diseases, diabetes, and other chronic conditions.
• Over-the-Counter (OTC) Products: Producing non-prescription products such as supplements and health-promoting medicines.
• Research & Development: Hengjingtang invests heavily in R&D, continually striving to improve existing products and develop new formulations. The company is involved in clinical research to ensure the safety and efficacy of its products.

Manufacturing and Quality Control
Hengjingtang operates state-of-the-art manufacturing facilities that comply with national and international standards, including GMP (Good Manufacturing Practices) certification. The company adheres to rigorous quality control processes to ensure that all products meet the highest standards of safety, quality, and efficacy.

Commitment to Innovation
Hengjingtang places a strong emphasis on scientific research and innovation. The company collaborates with research institutions and universities to advance pharmaceutical technologies and improve the effectiveness of its product lines. Hengjingtang's dedication to innovation ensures that it can continuously meet the evolving healthcare needs of its customers.